Navigation Links
U.S. Cancer Rate-Death Rate Combo Drops for 1st Time
Date:11/25/2008

ike heart disease, is by and large predictable and preventable, this is a very gratifying report," he said. "We have here proof that both the incidence and mortality of cancer overall have trended downward over recent years. This means that we are treating cancer more effectively when it occurs, but also preventing it outright more often."

Yet there is some discouraging news, Katz said. "Lung cancer death rates in women in the South and Midwest have continued to rise, due to higher rates of smoking. We should note, however, that after smoking rates fall, it takes some time to see that reflected in less cancer. So we might fix the basis for these disparities, and still see disparities for some time," he said.

"Cancer remains a leading cause of both premature death and misery in our society. And far more of that burden is preventable than progress to date reveals. You can minimize your own risk by taking four steps: Don't smoke, eat well, be active, and get screened," Katz said.

More information

To learn more about cancer, visit the American Cancer Society.



SOURCES: Ahmedin Jemal, D.V.M., Ph.D., director, Cancer Occurrence Office, American Cancer Society, Atlanta; David L. Katz, M.D., M.P.H., director, Prevention Research Center, Yale University School of Medicine, New Haven, Conn.; Dec. 3, 2008, Journal of the National Cancer Institute


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Some Breast Cancers May Regress on Their Own
2. Physicists receive patent for improved cancer therapy device
3. USC researchers identify novel approach for suppressing prostate cancer development
4. Mammograms may detect some cancers that would have otherwise regressed
5. Transfusions increase clot risk in hospitalized cancer patients
6. Foundation Venture Capital Group Invests in Company Working to Protect Healthy Tissue During Cancer Treatment
7. TargetScan Evaluation is Shown to Deliver Potentially Higher Cancer Detection Rate and More Accurate Assessment of Grade
8. Fresh Transfusions Improve Odds for Cancer Patients After Surgery
9. Varian Medical Systems to Exhibit the Latest X-Ray Image Detectors, X-Ray Tubes, and Cancer Treatment Technologies at RSNA This Year
10. Latin Women More Likely to Be Unhappy With Breast Cancer Treatment Decisions
11. Med school discovery could lead to better cancer diagnosis, drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Minneapolis Hosts National Conference on Tobacco or Health October 24-26 on Heels of Minnesota's Statewide, Smoke-Free Law 2Health News:Cepheid Schedules Teleconference and Webcast for Third Quarter 2007 Results 2Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 2Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 3Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 4Health News:Hundreds to Gather for Rally in Celebration of Right to Breathe Clean Air 2Health News:Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines 2Health News:Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines 3Health News:Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines 4Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 2Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 3Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 4
Other Medicine Technology:Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 2Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 3Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 4Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 5Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 6Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 7Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 8Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 9Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 2Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 3Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 4Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 5